Comment on CMS-2026-1256-0002
Intuitive Surgical Inc.OpposeBusiness
Summary: Intuitive, a medical technology manufacturer, opposes the proposed elimination of the alternative New Technology Add-on Payment (NTAP) and transitional pass-through (TPT) pathways for FDA-designated Breakthrough Devices. They argue that removing these pathways creates a significant burden on innovators, threatens the pipeline of new technologies, and could delay patient access to innovative medical devices.
See attached file(s)